TCL Archive In Brief: Oldham To Head Biological Response Modifiers Program; Walter, Namovicz Named Acting Heads August 8, 1980
TCL Archive FDA Committee Okays Leuprolide NDA, But Recommends Against Mitoxantrne, Epirubicin April 5, 1985
TCL Archive Geography Still An Issue For Centers: Durant Asks Is It “Holy Water” or Money April 26, 1985
TCL Archive Also In sudden policy change, NIH proposes one-year ban on consulting by employees. October 1, 2004